Keywords: ap, pharma, submits, apf530, trial, protocol, fda

AP Pharma submits APF530 trial protocol to FDA

Article | 30 January 2006

Print This

AP Pharma, a US specialty drugmaker, says it has submitted a protocol to the Food and Drug Administration for a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in